Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
(Probenecid + sulopenem etzadroxil) by Iterum Therapeutics for Urinary Tract Infections: Likelihood of Approval
(Probenecid + sulopenem etzadroxil) is under clinical development by Iterum Therapeutics and currently in Pre-Registration for Urinary Tract Infections. According...